First Wave BioPharma Inc.

NASDAQ: FWBI · Real-Time Price · USD
2.96
0.13 (4.59%)
At close: May 16, 2024, 10:00 PM

First Wave BioPharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a -138.77K n/a n/a n/a 138.77K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a 43.02K n/a n/a 12.29K 7.32K 23.41K 23.13K 22.85K 22.57K 22.29K 30.82K n/a n/a n/a n/a n/a
Gross Profit
n/a n/a -95.74K n/a n/a -12.29K 131.45K -23.41K -23.13K -22.85K -22.57K -22.29K -30.82K n/a n/a n/a n/a n/a
Operating Income
-638.86K -821.39K 1.13M -1.89M -3.43M -9.23M -4.09M -3.43M -4.18M -4.06M -2.28M 4.39M -5.41M -9.38M -11.17M -30.4M -9.28M -8.21M
Interest Income
n/a n/a -681 n/a n/a 228.00 224.00 229.00 205.00 1.87K 4.69K 2.66K 926.00 139.00 n/a n/a n/a 403.00
Pretax Income
-998.27K -1.26M -1.23M -1.9M -3.43M -9.29M -4.1M -3.43M -4.19M -4.07M -3.99M 4.39M -5.41M -9.63M -11.17M -30.4M -9.28M -7.69M
Net Income
-998.27K -1.26M -16.09M -2.58M -8.81M 5.57M -4.1M -3.43M -4.19M -4.09M -5.69M 4.39M -5.41M -9.87M -11.17M -30.4M -9.28M -7.69M
Selling & General & Admin
628.23K 805.56K 868.93K 1.69M 3.21M 8.65M 2.78M 2.42M 2.83M 2.7M 2.18M 2.9M 2.5M 4.41M 3.04M 6.02M 3.63M 5.7M
Research & Development
10.63K 15.83K 1.98M 207K 219.59K 565.96K 1.31M 1.01M 1.35M 1.36M 101.82K -7.29M 2.91M 4.98M 5.78M 24.38M 5.65M 2.52M
Other Expenses
n/a n/a 1.15K n/a n/a -653 -495 n/a -2.62K -1.11K 6.56K n/a n/a n/a -4.28K -568 898.00 n/a
Operating Expenses
638.86K 821.39K 2.85M 1.89M 3.43M 9.21M 4.09M 3.43M 4.18M 4.06M 2.28M -4.39M 5.41M 9.38M 8.81M 30.4M 9.28M 8.21M
Interest Expense
-36.07K -17.9K -73.63K 229.00 218.00 66.2K 7.05K 1.25K 5.18K 8.99K 6.19K 863.00 3.22K 5.61K 2.4K 742.00 2.95K 5.14K
Selling & Marketing Expenses
n/a n/a 19.61K n/a n/a -12.29K -7.32K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
n/a n/a 2.89M n/a n/a 9.23M 4.09M 3.43M 4.18M 4.06M 2.28M -4.39M 5.41M 9.38M 8.81M 30.4M 9.28M 8.21M
Income Tax Expense
n/a n/a 14.86M 685.72K -4.26M -14.86M n/a 229.00 2.56K 17.21K 1.71M -1.8K 2.29K 244.77K 2.4K 174.00 3.85K n/a
Shares Outstanding (Basic)
4.77M 4.77M 3.43M 4.55M 2.29M 1.76M 1.56M 378.3K 113.55K 114.03K 49.75K 228.77K 103.84K 74.02K 61.53K 44.49K 37.2K 26.36K
Shares Outstanding (Diluted)
4.77M 4.77M 3.43M 4.55M 2.29M 14.51M 1.56M 378.3K 113.55K 114.03K 49.75K 232.25K 103.84K 74.02K 61.53K 44.49K 37.2K 26.36K
EPS (Basic)
-0.21 -0.28 3.26 -0.59 -3.86 3.12 -2.63 -9.08 -36.89 -35.85 -114.42 19.20 -52.1 -133.36 36.64 -683.36 -249.42 -291.61
EPS (Diluted)
-0.21 -0.28 6.00 -0.59 -3.86 0.38 -2.63 -9.08 -36.89 -35.85 -114.42 18.91 -52.1 -133.36 36.64 -683.36 -249.42 -291.61
EBITDA
-638.86K -821.39K -1.33M -1.89M -3.43M -9.21M -4.09M -3.43M -4.18M -4.05M -3.97M 4.4M -5.4M -9.61M -8.68M -30.26M -9.14M -7.55M
EBIT
n/a n/a 16.75M n/a n/a -9.23M -4.09M -3.43M -4.18M -4.06M -3.98M 4.39M -5.4M -9.62M 519.03B -30.4M -9.28M -7.68M
Depreciation & Amortization
n/a n/a -26.93K n/a n/a 12.29K 7.32K 7.32K 7.32K 8.08K -1.69M 9.98K 8.24K -231.84K 137.2K 138.26K 133.88K 132.91K